Evidence map›Paper›PMID 27103162›Full record

ArticleBMC research notes2016

A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.

Kamini E Kuchinad, Heidi E Hutton, Anne K Monroe, Garrick Anderson, Richard D Moore, Geetanjali Chander

Abstract read
In one paragraph

Article in BMC research notes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kamini E KuchinadDepartment of General Internal Medicine, Johns Hopkins Hospital, Baltimore, MD, USA. Kkuchin1@jhmi.edu.
Heidi E HuttonDepartment of General Internal Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.
Anne K MonroeDepartment of General Internal Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.
Garrick AndersonUniversity of Maryland School of Medicine, Baltimore, MD, USA.
Richard D MooreDepartment of General Internal Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.
Geetanjali ChanderDepartment of General Internal Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Johns Hopkins HIV Clinical CohortU01DA036935 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 2014 to 2024
$14.9M
Leveraging Patient-Reported Outcomes to Improve Retention in HIV CareK23MH105284 · NIMH · JOHNS HOPKINS UNIVERSITY · PI MONROE, ANNE KRESS · 2014 to 2016
$525k
NIAID NIH HHS 7UM1AI06863NIAID NIH HHS P30 AI094189NIDA NIH HHS U01 DA036935NIDA NIH HHS U01DA036935NIMH NIH HHS 5K23MH105284-02NIMH NIH HHS K23 MH105284
6 · The paper itself

Abstract

backgroundPersons living with HIV (PLWH) and substance use/misuse experience significant barriers to engagement in HIV care at every step of the HIV care continuum including: (1) HIV testing and diagnosis (2) linkage to clinical care (3) retention in care pre-antiretroviral therapy (ART) (4) ART initiation and adherence (5) viral suppression. We qualitatively explored the facilitators of and barriers to participation in the HIV care continuum among PLWH with substance use/misuse.

methodsWe performed semi-structured in-depth interviews with 34 PLWH in care with recent substance use. The transcripts were analyzed in an iterative process using an editing style analysis. Interviews were conducted until thematic saturation was achieved.

resultsParticipants attributed an escalation in drug use at the time of diagnosis to denial of their disease and the belief that their death was inevitable and cited this as a barrier to treatment entry. In contrast, participants reported that experiencing adverse physical effects of uncontrolled HIV infection motivated them to enroll in care. Reported barriers to retention and adherence to care included forgetting medications and appointments because of drug use, prioritizing drug use over HIV treatment and side effects associated with medications. Participants described that progression of illness, development of a medication taking ritual and a positive provider-patient relationship all facilitated engagement and reengagement in care.

conclusionsPLWH with substance use engaged in care describe barriers to and facilitators of optimal engagement related to and distinct from substance use. Greater understanding of the biologic, psychological and social factors that promote and impair engagement in care can inform interventions and reduce the increased morbidity and mortality experienced by PLWH with substance use.

Indexed as

Qualitative ResearchAnti-HIV AgentsContinuity of Patient CareDrug MonitoringFemaleHealth Services AccessibilityHIV InfectionsHumansInterviews as TopicMaleMiddle AgedPatient Acceptance of Health CareSocial SupportSubstance-Related DisordersAnti-HIV AgentsAdherenceARTHIVHIV care continuumSubstance use

Identifiers

PMID27103162
PMCPMC4841053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.